Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Inventory (2018 - 2025)

TransMedics has reported Change in Inventory over the past 8 years, most recently at $6.5 million for Q4 2025.

  • Quarterly results put Change in Inventory at $6.5 million for Q4 2025, up 257.87% from a year ago — trailing twelve months through Dec 2025 was $7.7 million (down 7.63% YoY), and the annual figure for FY2025 was $7.7 million, down 7.63%.
  • Change in Inventory for Q4 2025 was $6.5 million at TransMedics, down from $6.9 million in the prior quarter.
  • Over the last five years, Change in Inventory for TMDX hit a ceiling of $10.1 million in Q3 2023 and a floor of -$4.1 million in Q4 2024.
  • Median Change in Inventory over the past 5 years was $2.2 million (2021), compared with a mean of $2.9 million.
  • Biggest five-year swings in Change in Inventory: skyrocketed 667.98% in 2022 and later crashed 260.16% in 2025.
  • TransMedics' Change in Inventory stood at $930000.0 in 2021, then soared by 107.53% to $1.9 million in 2022, then surged by 265.96% to $7.1 million in 2023, then plummeted by 158.57% to -$4.1 million in 2024, then surged by 257.87% to $6.5 million in 2025.
  • The last three reported values for Change in Inventory were $6.5 million (Q4 2025), $6.9 million (Q3 2025), and -$3.7 million (Q2 2025) per Business Quant data.